Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans (Q43541711)

24 November 2017

title

Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans (English)

1 reference

24 November 2017

Beglinger C

1

1 reference

24 November 2017

Degen L

2

1 reference

24 November 2017

Matzinger D

3

1 reference

24 November 2017

D'Amato M

4

1 reference

24 November 2017

Drewe J

5

1 reference

24 November 2017

publication date

1 April 2001

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

24 November 2017

published in

1 reference

24 November 2017

volume

280

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

R1149-54

1 reference

Dietary fat and the control of energy intake: evaluating the effects of fat on meal size and postmeal satiety

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

CCK antagonists and CCK-monoamine interactions in the control of satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Adaptation to high-fat diets: effects on eating behaviour and plasma cholecystokinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Is cholecystokinin a satiety hormone? Correlations of plasma cholecystokinin with hunger, satiety and gastric emptying in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Control of food intake. A physiologically complex, motivated behavioral system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Cholecystokinin elicits Satiety in Rats with Open Gastric Fistulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Physiology of the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Regulation of gastric emptying in humans by cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Role of cholecystokinin in the regulation of satiation and satiety in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Satiety effects of a physiological dose of cholecystokinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Cholecystokinin and leptin act synergistically to reduce body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Effect of a soup preload on reduction of food intake by cholecystokinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Comparative effects of caerulein on food intake and pancreatic secretion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

The direct and indirect controls of meal size

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Comparisons of the effects on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2001.280.4.R1149

10.1152/AJPREGU.2001.280.4.R1149

21 January 2018

Identifiers

DOI

0 references

1 reference